New study uncovers specifically how Covid-19 disrupted healthcare payer operations October 25, 2021 Read More
Covid-19 disrupted payer operations October 8, 2021 Covid-19 changed the landscape of healthcare. Pharma companies had to ramp up their digital outreach to continue uninterrupted business. Read More
Indegene strengthens its Pricing, Reimbursement and Market Access capabilities with Medical Marketing Economics, LLC acquisition August 30, 2021 Indegene, a technology-led healthcare solutions provider, today announced the acquisition of Medical Marketing Economics, LLC (MME), a global leader in Pricing, Reimbursement and Market Access (PRMA) services. Read More
How are patients’ perceptions about drug copays, pharmaceutical industry, and digitalization of healthcare evolving during COVID-19 pandemic? May 18, 2021 Read More
From regulatory approvals to launch: a comparison of time to market between the US and EU5 April 27, 2021 Read More
How are payers’ attitudes about home infusion evolving in the COVID environment? March 2, 2021 Payers have covered home infusion services as part of the medical benefit for years. With the effects of COVID-19 restricting access to hospitals and physician offices for elective procedures, the availability of home infusion services has increased in importance. Read More
Copay Accumulators: Shifting cost of care from plan sponsors to patients? January 27, 2021 Health insurers argue that copay accumulator programs (CAPs) incentivize patients to shift to less expensive generic alternatives. Read More
What impact will Trump’s most-favored-nation approach have on US drug pricing? October 20, 2020 Read More
